ロード中...
The Long Road to the First FDA Approved Gene Therapy: Chimeric Antigen Receptor T Cells Targeting CD19
Thirty years after initial publications of the concept of a chimeric antigen receptor (CAR), the U.S. Food and Drug Administration (FDA) approved the first anti-CD19 CAR T cell therapy. Unlike other immunotherapies such as immune checkpoint inhibitors and bispecific antibodies, CAR T cells are uniqu...
保存先:
| 出版年: | Cytotherapy |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7036015/ https://ncbi.nlm.nih.gov/pubmed/32014447 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jcyt.2019.12.004 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|